HEALTHPEAK PROPERTIES, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HEALTHPEAK PROPERTIES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.82B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $2.70B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $2.18B | Feb 3, 2026 |
| FY2022 | Dec 31, 2022 | $524.47M | Feb 8, 2023 |
| FY2022 | Sep 30, 2022 | $520.41M | Feb 8, 2023 |
| FY2022 | Jun 30, 2022 | $517.93M | Feb 8, 2023 |
| FY2022 | Mar 31, 2022 | $498.37M | Feb 8, 2023 |
| FY2022 | Dec 31, 2021 | $483.21M | Feb 8, 2023 |
| FY2022 | Sep 30, 2021 | $481.47M | Feb 8, 2023 |
| FY2022 | Jun 30, 2021 | $476.24M | Feb 8, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $603.99M | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $568.48M | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $527.42M | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $494.94M | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | $471.33M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $436.49M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $144.33M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $144.22M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $524.28M | Feb 13, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.35M | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $243.14M | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $306.01M | Feb 3, 2026 |
| FY2022 | Dec 31, 2022 | $6.53M | Feb 8, 2023 |
| FY2022 | Sep 30, 2022 | $353.97M | Feb 8, 2023 |
| FY2022 | Jun 30, 2022 | $68.34M | Feb 8, 2023 |
| FY2022 | Mar 31, 2022 | $71.61M | Feb 8, 2023 |
| FY2022 | Dec 31, 2021 | $28.76M | Feb 8, 2023 |
| FY2022 | Sep 30, 2021 | $54.71M | Feb 8, 2023 |
| FY2022 | Jun 30, 2021 | $276.28M | Feb 8, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.25B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $1.07B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $956.24M | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $900.26M | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | $795.25M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $758.43M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $846.07M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $848.71M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $847.04M | Feb 13, 2020 |
| FY2018 | Dec 31, 2016 | $1.21B | Feb 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.34B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $19.94B | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | $15.70B | Feb 4, 2025 |
| FY2023 | Dec 31, 2022 | $15.77B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $15.26B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $15.92B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $14.03B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $12.72B | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $14.09B | Feb 14, 2019 |
| FY2018 | Dec 31, 2016 | $15.76B | Feb 14, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.03B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $10.88B | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | $8.77B | Feb 4, 2025 |
| FY2023 | Dec 31, 2022 | $8.48B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $8.11B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $8.57B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $7.37B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $6.21B | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $8.49B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $9.82B | Feb 13, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.50B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $8.40B | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | $6.35B | Feb 4, 2025 |
| FY2023 | Dec 31, 2022 | $6.65B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $6.52B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $6.73B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $6.09B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $5.94B | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $5.30B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $5.55B | Feb 13, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.53M | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $68.53M | Feb 3, 2026 |
| FY2025 | Mar 1, 2024 | $51.00M | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | $18.03M | Feb 4, 2025 |
| FY2023 | Dec 31, 2022 | $18.00M | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $18.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $18.00M | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $17.00M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $47.00M | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $47.00M | Feb 14, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $467.46M | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $119.82M | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | $117.64M | Feb 4, 2025 |
| FY2024 | Dec 31, 2022 | $72.03M | Feb 4, 2025 |
| FY2024 | Dec 31, 2021 | $158.29M | Feb 4, 2025 |
| FY2023 | Dec 31, 2020 | $44.23M | Feb 9, 2024 |
| FY2022 | Dec 31, 2019 | $80.40M | Feb 8, 2023 |
| FY2021 | Dec 31, 2018 | $53.98M | Feb 9, 2022 |
| FY2018 | Dec 31, 2017 | $55.31M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $94.73M | Feb 13, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.85B | Feb 3, 2026 |
| FY2024 | Dec 31, 2024 | $8.72B | Feb 4, 2025 |
| FY2023 | Dec 31, 2023 | $6.88B | Feb 9, 2024 |
| FY2022 | Dec 31, 2022 | $6.50B | Feb 8, 2023 |
| FY2021 | Dec 31, 2021 | $6.17B | Feb 9, 2022 |
| FY2020 | Dec 31, 2020 | $6.62B | Feb 10, 2021 |
| FY2019 | Dec 31, 2019 | $6.30B | Feb 13, 2020 |
| FY2018 | Dec 31, 2018 | $5.48B | Feb 14, 2019 |
| FY2017 | Dec 31, 2017 | $7.79B | Feb 13, 2018 |
| FY2016 | Dec 31, 2016 | $9.10B | Feb 13, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 8, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 13, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 8, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 13, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 695.04M | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | 699.49M | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | 547.16M | Feb 4, 2025 |
| FY2023 | Dec 31, 2022 | 546.64M | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | 539.10M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | 538.41M | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | 505.22M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | 477.50M | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | 469.44M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | 468.08M | Feb 13, 2018 |